Microvessel Density: Integrating Sex-Based Differences and Elevated Cardiovascular Risks in Metabolic Syndrome

Area of Science:

• Cardiovascular Science
• Endocrinology
• Metabolic Disease Research

Background:

• Metabolic syndrome (MetS) involves hypertension, insulin resistance, and obesity, linked to vasculopathy and reduced microvessel density (MVD).
• Microvascular dysfunction in MetS can cause perfusion-demand mismatch, exacerbating disease progression through positive feedback loops.
• Sexual dimorphism in cellular mechanisms influences cardiovascular disease and ischemic event risk, with estrogen being protective and androgens potentially detrimental.

Purpose of the Study:

• To review the effects of MetS on MVD.
• To examine sex-based differences in MetS components and cardiovascular risk.
• To discuss translational relevance and interventions considering sex-based variations.

Main Methods:

• Literature review of studies on metabolic syndrome, microvascular density, and cardiovascular disease.
• Analysis of research on sexual dimorphism in metabolic and cardiovascular pathways.
• Synthesis of information on hormonal influences (estrogen, androgens) on vascular health.

Main Results:

• MetS is associated with reduced MVD (rarefaction), contributing to cardiovascular disease risk.
• Significant sex differences exist in MetS pathophysiology and cardiovascular risk profiles.
• Estrogen demonstrates protective effects on the endothelium, while androgens may pose risks.

Conclusions:

• Understanding sex differences in MetS and MVD is crucial for targeted therapeutic strategies.
• Hormonal influences play a key role in the differential risk of cardiovascular events between sexes.
• Future interventions should consider these sex-based disparities for improved patient outcomes.